ELEbba Lohmann

Ebba Lohmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ebba Lohmann has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Alejandra Darling

    Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain

    1 shared publication
  • Alexander Münchau

    Institute of Systems Motor Science, CBBM, University of Lübeck Lübeck Germany

    1 shared publication
  • Alfons Macaya

    Pediatric Neurology, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain

    1 shared publication
  • Anatol Kivi

    Department of Neurological Rehabilitation and Physical Therapy, Vivantes Klinikum Spandau, 13585 Berlin, Germany

    1 shared publication
  • Andrea Bevot

    Clinic for Paediatrics and Adolescent Medicine, Department of Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology, Social Paediatrics, University Hospital Tübingen, Tübingen, Germany

    1 shared publication
  • Andrea Stenner

    Movement Disorders Competence Center, Medizinisches Versorgungszentrum Zwickau, 08060 Zwickau, Germany

    1 shared publication

Latest Publications

  • Open Access

    Dystonia 3×3: A Training Guideline for Beginners in Botulinum Neurotoxin Treatment of Cervical Dystonia

    by Sebastian Paus, Andreas Funke, Jürgen Hamacher, Bernhard Haslinger, Jan Heckelmann, Chi Wang Ip, Wolfgang H. Jost, Anatol Kivi, Stephan Klebe, John-Ih Lee, et al.

    Cervical dystonia (CD) is a hyperkinetic movement disorder characterized by involuntary muscle contractions leading to abnormal postures of the head and neck. The injection of botulinum neurotoxin type A (BoNT-A) into the muscles involved is the treatment of choice for CD. BoNT-A therapy of CD requires appropriate training, which has not been standardized in Germany. To address the key challenges in BoNT-A education, an expert panel developed a simplified step-by-step treatment guideline for beginners, adapted from the established Col-Cap-Concept (“Dystonia 3×3”). Based on expert consensus, recommendations were developed for the core clinical elements of BoNT-A treatment in CD—recognition of the movement pattern, identification of target muscles, development of an injection plan, ultrasound-guided injection, and dosing, taking into account the target audience of the guideline. As such, Dystonia 3×3 provides a user-friendly beginner’s guidebook, enhancing accessibility and standardization of CD treatment training. Further research is required to evaluate its clinical efficacy and suitability for training.

  • Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)

    by Lorenzo Nanetti, Mary Kearney, Sylvia Boesch, Lucie Stovickova, Juan Darío Ortigoza-Escobar, Alfons Macaya, David Gomez-Andres, Emmanuel Roze, Maria-Judit Molnar, Nicole I. Wolf, et al.

    Background Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions. Aim To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND). Methods Members of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network. Results Twenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice. Conclusions This survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.


  • Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia

    by Gamze Guven, Başar Bilgic, Zeynep Tufekcioglu, Nihan Erginel Unaltuna, Hasmet Hanagasi, Hakan Gurvit, Andrew Singleton, John Hardy, Murat Emre, Cagri Gulec, et al.

    Progranulin (GRN) gene mutations are a major cause of frontotemporal dementia (FTD). Most mutations identified to date are null mutations, which are predicted to cause the pathology via haploinsufficiency. Decreased peripheral progranulin protein (PG